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a  b  s  t  r  a  c  t
Non-homologous  end  joining  (NHEJ)  repairs  DNA  double-strand  breaks  generated  by  DNA  damage  and
also  those  occurring  in  V(D)J  recombination  in immunoglobulin  and  T cell  receptor  production  in  the
immune  system.  In NHEJ  DNA-PKcs  assembles  with  Ku  heterodimer  on  the  DNA  ends  at  double-strand
breaks,  in  order  to bring  the broken  ends  together  and  to assemble  other  proteins,  including  DNA  ligase
IV  (LigIV),  required  for DNA repair.  Here  we focus  on  structural  aspects  of the  interactions  of  LigIV with
XRCC4,  XLF,  Artemis  and  DNA  involved  in  the  bridging  and  end-joining  steps  of NHEJ.  We  begin with  a
discussion  of the role of  XLF,  which  interacts  with  Ku  and  forms  a hetero-ﬁlament  with  XRCC4;  this  likely
forms  a scaffold  bridging  the  DNA  ends.  We  then  review  the  well-deﬁned  interaction  of  XRCC4  with  LigIV,rtemis, DNA ligase IV
RCC4
LF
ernunnus
IG4  syndrome
and  discuss  the  possibility  of  this  complex  interrupting  the  ﬁlament  formation,  so  positioning  the  ligase
at  the  correct  positions  close  to  the  broken  ends.  We  also  describe  the  interactions  of  LigIV with  Artemis,
the  nuclease  that prepares  the ends  for ligation  and  also  interacts  with  DNA-PK.  Lastly  we review  the
likely  affects  of Mendelian  mutations  on  these  multiprotein  assemblies  and  their  impacts  on  the form  of
inherited  disease.
©  2014  The  Authors.  Published  by  Elsevier  B.V. Open access under CC BY license.. Introduction
Non-homologous end joining (NHEJ) is an evolutionarily con-
erved repair system for DNA double-strand breaks (DSBs) [1]. NHEJ
ot only repairs DNA ends generated by DNA damage but also joins
hose created by V(D)J recombination and class switch recombi-
ation, which are joined in a strictly regulated way in order to
aintain the gene integrity for immunoglobulin and T cell recep-
ors in the immune system. NHEJ involves two pathways: classical
HEJ (referred to as NHEJ in this review) and alternative end joining
AEJ). NHEJ and AEJ use different proteins and AEJ requires micro-
omology of DNA ends [2–6]. In this review, we focus on structural
spects of NHEJ.
The  core components of NHEJ are the Ku70/80 heterodimer
Ku), DNA-dependent protein kinase catalytic subunit (DNA-PKcs),
RCC4, DNA ligase IV (LigIV) and XLF/Cernunnus (XLF). Ku and
NA-PKcs together with DNA form the DNA-PK complex, and
RCC4, LigIV and XLF form the NHEJ ligase complex. In addi-
ion, NHEJ requires Artemis, DNA polymerase  and  (pol 
nd pol , respectively), terminal dinucletidyltrasferase (TdT),
∗ Corresponding author. Tel.: +44 0 1223 766029.
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568-7864 © 2014 The Authors. Published by Elsevier B.V. Open access under CC BY license.polynucleotide kinase-phosphatase (PNKP), aprataxin (APTX) and
aprataxin-PNKP-like factor (APLF) [1]. 53BP1 and RIF1 play impor-
tant roles in responding to DSBs in the early stages of NHEJ [7–12].
Thus, the DNA-PK and NHEJ ligase complexes share many common
partners, for example, XLF, Ku and DNA itself, and contribute at
DNA ends to much larger multicomponent assemblies, which vary
over space and time depending on the type of DSB (Fig. 1).
2.  DNA-PK complex
Most  work on understanding the D NA-PK sub-complex has
been focused on DNA-PKcs, the catalytic subunit, which belongs to
the phosphoinositide 3-kinase (PI3K)-related protein kinase (PIKK)
family. Several groups have analyzed the structure of DNA-PKcs
using single particle reconstruction from cryo-electron microscopy
[13–18]. Although these models differ quite radically between
themselves, general features such as head/crown containing the
kinase structure and a large circular base can be seen in all.
Sibanda  et al. (2010) produced crystals and have reported the
structure of DNA-PKcs in complex with the C-terminal domain
of Ku80 at 6.6 A˚ resolution [19]. In the electron density helical
regions were clearly visible indicating that most of the structure
was dominated by HEAT or other related -helical repeats. How-
ever, the electron density for the chains linking these helices was
T. Ochi et al. / DNA Repair
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Big. 1. Schematic representation of the NHEJ network. Grey lines indicate
rotein–protein interactions [64,80,88–90,161–170].
issing in most cases, making the polypeptide path difﬁcult to
ollow; the exception was the kinase domain where prior knowl-
dge of the fold assisted the interpretation. Nevertheless, in the
-terminal region helices are clearly identiﬁed in HEAT repeats and
olded into a circular structure, resembling a cradle when viewed
rom the side (see Fig. 2). The C-terminal region, which forms the
ead/crown of the molecule, is also predominantly -helical. It
ontains the protein kinase domain, which is involved in phos-
horylation of other proteins as well as autophosphorylation and is
ell positioned for access to substrates (Fig. 2). Recently Pavletich
nd colleagues have solved the structure of the mammalian target
f rapamycin (mTOR), a further phosphoinositide 3-kinase-related
rotein kinase, which controls cell growth in response to nutrients
nd growth factors [20]. The arrangement of helices corresponds to
hat conservatively reported in the structure of DNA-PKcs. Ongo-
ng X-ray structural work (BL Sibanda, D Chirgadze and TL Blundell,
npublished) at 4.3 A˚ resolution has deﬁned the positions of all the
quivalent helices and suggests a number of putative interaction
egions shared with mTOR.
The  poor resolution of the analysis and the fact that the Ku80
-terminal domain also consists of -helical HEAT repeats makes
t difﬁcult to locate this domain in the electron density with any
ig. 2. Molecular surface of the DNA-PKcs structure viewed perpendicular to the ring stru
f  the molecule is as follows: the ring structure is green; the forehead that is part of the 
-terminal part is magenta, and the kinase domain is yellow (Adapted from ESRF Highli
lundell). 17 (2014) 98–109 99
certainty  but it likely resides within the large N-terminal circular
structure. This domain is a good candidate for DNA binding, and
a putative DNA-binding sub-domain was proposed in the cryo-EM
structure reported earlier [17]. Indeed the evolution of a large head
domain conserved in other PI3K-related protein kinases together
with a large ring structure allows DNA-PKcs to function both as an
enzyme involved in DNA damage signaling and as a platform for
DNA, Ku and other proteins engaged in the repair of broken DNA.
3.  End bridging
XLF,  a key protein in NHEJ, was discovered independently
through yeast two-hybrid screening for XRCC4 interactors and
investigations of a group of patients with growth retardation,
microcephaly and immunodeﬁciency characterized by a profound
T + B lymphocytopenia [21–23]. Down-regulation of XLF in cells
causes an increase of radiosensitivity, sensitivity towards anti-
cancer drugs, DSB repair defects and prolonged phosphorylation
of histone H2AX [22]. Cells from patients carrying mutations in
the XLF gene have impaired ability to respond to replication stress
[24]. XLF is less abundant in cells compared to XRCC4 and LigIV
[22]. XLF, like XRCC4, does not have enzymatic function itself, but
rather performs its role in NHEJ as a scaffold protein to stabilize
LigIV/XRCC4 at broken DNA ends. It enhances the LigIV/XRCC4
end-joining process speciﬁcally through LigIV readenylation fol-
lowing ligation [25–28]. How exactly XLF improves LigIV function
and whether XLF is involved in early synapsis of NHEJ are central
questions for investigation.
Structural  studies of XLF and the XRCC4/XLF complex provide
powerful starting points for an investigation of the functional
mechanism of XLF. Despite the low sequence identity, the crys-
tal structures of XLF and XRCC4 demonstrate that the two proteins
are homologous homodimers comprising globular head domains
and C-terminal helices that form coiled-coil tail structures [29–32].
The head domains form seven-stranded antiparallel -sheets sand-
wiching a helix-turn-helix (HTH) motif between 4 and 5, but XLF
contains an extra helix in the N-terminal region. Whereas the tail
structure of XRCC4 comprises an elongated coiled-coil, the equiva-
lent extended helix 4 of XLF is followed by further helices, 5 and
cture (left panel) and in the plane of the ring structure (right panel). The color code
ring structure is light purple; the putative DNA binding domain is pink; the larger
ghts, Newsletter, and Management Reports 2010 by BL Sibanda, D Chirgadze & TL
100 T. Ochi et al. / DNA Repair
Fig. 3. The structure of the XRCC4/XLF complex. (A) XRCC4/XLF structures solved in
four different groups [34–36,38]. One turn of XRCC4/XLF ﬁlament, which contains
6  copies of each XRCC4 and XLF molecules, is generated for comparison. Superim-
position of the ﬁrst XLF dimer molecules demonstrates varying curvatures of the
ﬁlaments. (B) Superimposition of the head domains from XLF, XRCC4 and SAS-6.
6-7  and HTH are closer together in XLF than in XRCC4 and SAS-6. The PDB codes
for  structures here are 1IK9 (XRCC4), 2QM4 (XLF) and 2Y3V (SAS-6) [39,40,51]. (C)
The protein–protein interface of XRCC4/XLF, located in the head domain of each pro-
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fein. The hydrophobic interface is shown in the top panel, while the bottom panel
hows the polar interaction (indicated by grey dashed line). XLF is colored in red
ink and XRCC4 is in deep purple. The XRCC4/XLF structure used is from [45].
6; these fold back around the coiled-coil formed by 4 so that the
-termini come close to the 1 helices of the head domains.
Mutagenesis studies have demonstrated the interactions
etween XRCC4 and XLF are through head domains of each pro-
ein, and key interactions are conserved, exposed and located in
TH motif and 6–7 structure for both proteins [32,33]. These key
esidues are symmetrically related by the dyads of the XRCC4 and
LF homodimer head domains, suggesting that XRCC4/XLF might
orm higher order polymers. Crystal structures, SAXS (small angle
-ray scattering) and nanospray mass spectrometry of XRCC4/XLF
both of which are C-terminal truncated) conﬁrm this predic-
ion [34–38]. Four structures solved in different laboratories show
imilar alternating XRCC4/XLF helical polymers with left-handed
ix-fold screw axes (Fig. 3A) [34–36,38]. The binding of the two pro-
eins generates a tilt angle between the pseudo dyads relating the
ead domains and coiled-coil tail structures. The four XRCC4/XLF
tructures differ in the angles of rotation between the helical-tail
tructures of XRCC4 and XLF dimers, and this in turn leads to differ-
nces of curvature and sizes of the central cylindrical cavities when
RCC4/XLF forms higher order polymers [34–36,38] (Fig. 3A). The
ffects of a small twist between two head domains, with the inter-
ction anchor regions still in touch, are ampliﬁed through the long
ail structures, demonstrating that XRCC4/XLF ﬁlaments are ﬂexible
nd elastic (Fig. 3C).
XLF  has longer structures in the HTH loop and 6-7 strands than
n XRCC4, and the distances between the HTH and 6-7 are less
or XLF than XRCC4 (Fig. 3B). Crystal structures show that the core 17 (2014) 98–109
XRCC4/XLF  interface is formed mainly through hydrophobic inter-
action. The tips of these loops (2-3 and 6-7) are in close proximity
and form a hydrophobic patch in XLF. Key residue L115 in 6-7
inserts into the hydrophobic pocket of XRCC4 (formed by 1-2 and
6-7) created by residues M61, L101 and F106 (Fig. 3C Top). XLF
L65 (in 2-3 loop) aligns next to the XRCC4 hydrophobic pocket.
In addition, XRCC4/XLF is further stabilized by polar interactions.
Residues from XLF 2-3 loop R64 and T66 interact with XRCC4 E55
(in 1) and S105 (in 7), respectively (Fig. 3C Bottom). Although
the interactions between XRCC4 and XLF protomers in the ﬁbres
are mediated through head domains, the C-terminal structures of
XRCC4 and XLF impact positively on the strength of the interaction
[36,38].
The identiﬁcation of a rather small and ﬂexible interaction
region between XRCC4 and XLF should allow small molecules or
peptides to be designed to disrupt the XRCC4/XLF interaction.
Over-expression of XRCC4 mutants, which cannot bind to XLF,
increase the radiosensitivity of wild-type CHO cells [39]. Thus,
small molecules that inhibit XLF and XRCC4 interaction might
prove beneﬁcial to cancer patients for radiochemotherapy treat-
ment. Interestingly, crystal structures of the N-terminal regions of
the centriole protein SAS-6 have revealed a protein fold similar to
those of XLF and XRCC4 [40–42]. Alignment of the head domains of
XLF, XRCC4 and SAS-6 shows the same general folding, but a greater
structural similarity between XRCC4 and SAS-6 in relative posi-
tioning of 6-7 loop and HTH structure (Fig. 3B). Indeed a higher
order SAS-6 complex is formed through equivalent head-to-head
interactions as seen in the XRCC4/XLF complex and coiled-coil tails
of the SAS-6 dimers extend outwards towards the assemblies of
microtubules.
DNA interactions with individual XRCC4 and XLF molecules
are not strong and large pieces of DNA are required for stable
protein–DNA interactions [27,43]. Andres and co-workers [45]
have shown that XLF K293 and XRCC4 E170 and R192 are key
residues for individual protein interaction with DNA. The XLF C-
terminal is crucial for the interaction of the XRCC4/XLF with DNA.
Thus, only full length XRCC4/XLF can mediate the DNA-bridging
effect. Addition of LigIV BRCT domain or use of truncated XLF
and XRCC4 proteins disables the DNA-bridging property. On the
basis of these observations, two  types of interaction are implicated
in mediating DNA bridging: ﬁlament–DNA and ﬁlament–ﬁlament.
Disruption of either leads to failure of the DNA-bridging process.
The LigIV BRCT domain-binding site on XRCC4 overlaps with the
probable region of XRCC4 tetramerization. Therefore this ﬁlament-
ﬁlament interaction could come from the tetramerization of XRCC4
[35]. XRCC4/XLF-ﬁlament assemblies seen in both crystal struc-
tures and EM studies [34–36,38], and strong DNA binding and
bridging could therefore achieved through XRCC4/XLF ﬁlament
bundles containing more than one copy of the XRCC4/XLF ﬁla-
ment. Ku and DNA-PKcs can mediate DNA synapsis [44]. XRCC4/XLF
DNA bridging does not require the presence of Ku and DNA-PKcs
[35]. Since Ku binds to DNA damage sites before XRCC4 and XLF,
it is not known whether Ku can further improve XRCC4/XLF DNA
bridging or whether they share some degree of redundant func-
tion. The C-terminal structures of XRCC4 and XLF are both targeted
for phosphorylation by DNA-PKcs [45,46]. Phosphorylation of XLF
residues in the unstructured C-terminal region has no effect on XLF
recruitment to damaged chromatin, DNA binding and repair efﬁ-
ciency [47,48]. But the phosphorylation of XRCC4/XLF by DNA-PKcs
can disassemble the XRCC4/XLF ﬁlament formation [39]. Therefore
DNA-PKcs may  be one of factors involved in XRCC4/XLF ﬁlament
regulation.The crystal structure of XRCC4 in complex with the BRCT
domains of LigIV shows that the second BRCT domain of LigIV
(BRCT2; residues 815-911) interacts with the coiled-coil region of
XRCC4 and is positioned close to the head domain of one XRCC4
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rotomer [49,50]. The presence of BRCT domains bound to XRCC4
oes not interfere with the formation of an individual XRCC4/XLF
lament. However, in the presence of full length LigIV, ﬁlament for-
ation is disrupted, presumably due to the presence of the LigIV
atalytic domain [51], which may  limit access of XLF to one side of
he XRCC4 homodimer head domain and therefore reduce ﬁlament
ormation. This termination of the XRCC4/XLF ﬁlament formation
y LigIV could be a regulatory process important for the role of
he ﬁlament in the DNA double-strand break damage repair, as
he XRCC4/XLF polymer would be terminated, thereby placing the
igase near a DNA end.
Alignment-based gap ﬁlling by DNA polymerase pol and pol
n whole-cell extracts is completely dependent on XLF [52]. In
RCC4 deﬁcient cell lines, disruption of the interaction between
LF and XRCC4 using XRCC4 mutants can restore the signal end
oining, but not the coding end-joining function [39]. Therefore it
s tempting to explain these functions of XLF in terms of its ability
o form ﬁlaments with XRCC4, which stabilize and align the DNA
nds, increasing DNA ligation efﬁciency.
The ﬂexibility of the XRCC4/XLF ﬁlament opens up the possi-
ility that it might wrap around chromatin and interact with DNA
nd histones. The DNA binding region of XLF would be located on
he inner side of the XRCC4/XLF helical structure. DNA would wrap
round the outer histones of the nucleosome as a left-handed heli-
al structure; the XRCC4/XLF is also a left-handed helical ﬁlament
tructure, although the helix pitch is much greater than that of DNA
uper-helical packing in the nucleosome. However, it could stabi-
ize DNA strands after nucleosome disassembly and damaged DNA
s exposed for ligation. Live cell imaging techniques have identi-
ed the immediate recruitment of XLF to laser-induced DSBs with
nly Ku protein bound in vivo, and the presence of XRCC4 can sta-
ilize XLF-DNA interaction through slowing of the highly dynamic
xchange rate between bound and free XLF and DNA [53]. Protein
nteraction assays have conﬁrmed the interaction between the core
tructure of Ku and the extreme C-terminal of XLF only in the pres-
nce of DNA while the presence of Ku abolished the DNA-length
ependency of the XLF–DNA association [53]. It is also possible
o accommodate Ku70/80 heterodimer within the helical ﬁbre of
RCC4/XLF [44].
In  addition to the proteins bound within the central cavity of
he XRCC4/XLF helical structure, there may  be other NHEJ proteins
ssembled on the helical tail structures of XLF and XRCC4, which
re pointing outwards; this would be analogous to the assembly
f proteins on the coiled-coil C-terminal regions in SAS-6. While
igIV can bind to the XRCC4 coiled-coil tail, further proteins can also
nteract with the C-terminal extension of XRCC4, for example PNKP
54,55]. The folded-back loop sequence between XLF 4 and 5 is
volutionarily conserved. Site-directed mutagenesis studies of XLF
t L174, R178 and L179, which are all located in this evolutionarily
onserved hinge region, reduces the stimulation of the DNA end-
igation activity without affecting the association with XRCC4 or
NA [32]. This XLF conserved region of unknown function may  bind
o other, as-yet unidentiﬁed NHEJ proteins.
Recent studies in a mouse model have shown that XLF func-
ionally overlaps with ataxia telangiectasia-mutated protein (ATM)
nd XLF/ATM double-deﬁciency severely impairs T- and B-cell
evelopment by impairing V(D)J recombination [56]. A possible
xplanation is that XLF inﬂuences processes such as DNA end
ethering and protecting, which are also mediated by ATM and
2AX [56]. Therefore, the function of XRCC4/XLF may  not only be
estricted to the ﬁnal DNA-end ligation step, it could assemble in
arly DNA synapsis right after Ku is recruited to the DNA dam-
ged ends. The XRCC4/XLF helical ﬁlament may  act as a dynamic
nd regulated “reaction shell”, which stabilizes chromatin near IR
oci, and gathers Ku70/80 and DNA-PKcs together for efﬁcient NHEJ
unction. 17 (2014) 98–109 101
4. End processing
End  processing has been structurally well studied with and
without DNA. There are excellent reviews on structural studies of
the X family DNA polymerase and PNKP [57,58]. Recent crystallo-
graphic studies of APTX have provided insights into how AMP is
removed from 5′-adenylated DNA [59,60]. Here we concentrate on
structural aspects of Artemis, mutation of which can cause radio-
sensitive severe-combined immune deﬁciency (RS-SCID) [61].
Excellent reviews on biological and biochemical aspects of Artemis
can be found elsewhere [62,63]. Artemis, a nuclease belonging to
the metallo--lactamase superfamily [61,64], acquires endonucle-
ase activity by forming a complex with DNA-PKcs, which is essential
for the hairpin opening in V(D)J recombination [64]. Artemis itself
has been associated with a 5′-to-3′ exonuclease activity [64] but a
recent study suggests that this may  arise from other exonucleases
co-puriﬁed from expressed cells [65]. For instance, a homologue of
Artemis, RNase J, carries both endo- and 5′-to-3′ exonuclease activ-
ities [66,67] and loses both activities upon mutation of key residues
in its catalytic core [68]. However, mutations of conserved residues
in Artemis impair only its endonuclease function [69]. As was sug-
gested by the authors, Artemis might have sites that are responsible
for the exonuclease activity.
Artemis  has core metallo--lactamase (-Lact) and -CASP
domains, which are conserved in nucleic acid-processing enzymes,
as well as a C-terminal domain (Art-Cter), which is unique to
Artemis [61,70]. Since the crystal structures of human paralogs of
Artemis, CPSF-73 [71], Apollo and SNM1A (Unpublished structures;
PDB codes: 3ZDK and 4B87) are available in the Protein Data Bank
and the catalytic core of Artemis shares 32 and 26% sequence iden-
tity with those of Apollo and SNM1A, the structures in complex with
zinc atoms can be used to build a homology model of Artemis. The
model, created using Modeller [72], shows a cleft between the -
Lact and -CASP domains and interestingly that the -Lact domain
is comprised of two polypeptides separated by the -CASP domain
(Fig. 4A).
Conserved motifs 1-4 and A-C [70] are located in the -Lact
domain and are involved in the coordination of the catalytic diva-
lent metal ions, which are zinc in most members of the superfamily.
In the catalytic core, a zinc atom is likely to be coordinated by H33,
H35 and H115 (Fig. 4 B) because the equivalent zinc is present in
the structure of the human paralogs. Although two zinc ions are
present in the structures of CPSF-73 and Apollo, the metal ion inter-
acting with acidic residues D37 & D136 and possibly E5 and E296
in Artemis could be magnesium and/or manganese for Artemis
[64,69,73,74]. D165 is likely to form hydrogen bonds with the main-
chain amides of F137 & T167 and the side chain of H319, which is
a key residue for the Artemis activity [69,75], suggesting that it is
structurally important. The equivalent residue of H319 in Apollo
interacts with a sulfate ion and tartaric acid implying that the histi-
dine may  bind DNA. Alternatively, the divalent ion might re-arrange
to be coordinated by H319 and/or D165 during nuclease catalytic
activity.
The sulfate superimposes well on a phosphorothioate of an
RNA analog in the structure of an archaeal RNase belonging to
the -CASP family (PDB codes: 3IEM), indicating that the sulfate
mimics a scissile phosphate. The structure of T. thermophilus RNase
J in complex with RNA shows the presence of a pocket that 5′
monophosphate binds via direct contacts with H243, H372, S374,
G375 and H376 [76]. In the archaeal structure, the 5′ phosphoro-
thioate forms a salt bridge with R227 and a hydrogen bond with
S378 (Fig. 4D), which are equivalent to H243 and S374 of the RNase
J. SNM1A and Apollo have well-conserved lysines K883 & K186 and
serines S992 & S274 at the equivalent positions of H243 and S374
of the RNase J. Indeed, K186 of Apollo makes a salt bridge with co-
crystallized tartaric acid. Artemis is likely to have a similar serine
102 T. Ochi et al. / DNA Repair 17 (2014) 98–109
Fig. 4. Structural model of human Artemis. (A) Overall structural model of Artemis. -Lact and -CASP are shown in pink and emerald green, respectively. The C-terminal
fold-back of -Lact is highlighted with light green. Positions of residues, the missense mutations of which are found in patients carrying Artemis deﬁciency, are shown in
s tion. 
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otted lines denote hydrogen bonds.
317 but interestingly has a conserved tyrosine Y212 instead of
ysine [70]. The difference is likely to be important for distinguish-
ng exonuclease from endonuclease activity. In addition, Artemis
s likely to have a longer loop than Apollo and SNM1A just after
he ﬁrst helix. Interestingly, the loop has a conserved-basic patch,
hich might bind the backbone of DNA.
Although the function of the -CASP domain is not clear from
he apo-structures, by analogy with the structure of archaeal (PDB
ode: 3IEM) and bacterial [76] orthologs of Artemis, the domain
ay stabilize the conformation of nucleic acids in order to enable
heir cleavage. Interestingly, the -CASP domain of Artemis and
ts paralogs have grooves with shallow pockets, which might bind
NA (Fig. 4C).
The  C-terminal 300 residues (Art-Cter), which follow the core
etallo--lactamase and -CASP domains, are predicted to be
ostly unstructured and seem to have a function in regulating
rtemis endonuclease activities [73,77,78]. The details of how Art-
ter controls the endonuclease activity remain to be resolved.
mportantly, the region has the DNA-PKcs and LigIV-binding motifs
residues 399–404 and 485–495, respectively) [79,80]. Recent crys-
allographic studies of the LigIV-binding region and LigIV complex
how that Artemis and the ﬁrst two helices of LigIV form a three-
elical bundle mainly through hydrophobic interactions (Fig. 5B)
81,82]. Although the nature of the interaction remains to be inves-
igated, it is clear that Artemis needs both the LigIV and DNA-PKcs(B) The catalytic center of Artemis. The same color scheme as (A) is used here. (C)
up view of the catalytic center of an archaeal RNase (PDB code: 3IEM; unpublished).
interactions for an efﬁcient coding-joint formation in V(D)J recom-
bination [80].
In  addition to these interactions, Art-Cter has PIKK phosphory-
lation sites concentrated after the LigIV-binding region [79,83–85].
The exact functions of the phosphorylations are not clear but they
affect cell cycle [83,85] and localization [79]. If Art-Cter were highly
phosphorylated after DNA damage, the net change of the region
would be negative. Given that the similarity between a backbone
phosphate and a phosphorylated sidechain, the phosphorylated C-
terminal might interact with DNA-binding proteins including LigIV
and regulate their functions. Indeed, there are examples of dynamic
interactions between multi-phosphorylated peptides and globu-
lar domains [86]. Intriguingly, Artemis mutants lacking residues
after T432 alter the N addition in V(D)J recombination [87], indi-
cating that the region is important for TdT and/or pol  functions.
Since the truncated region has the LigIV-binding region, it is not
clear whether LigIV or phosphorylation inﬂuence the polymerases,
although both may  do so because the polymerase interacts with
Ku/LigIV/XRCC4 in a DNA-dependent manner [88–90].
5.  End joiningDNA-end joining is carried out by the NHEJ ligase complex
LigIV/XRCC4/XLF. This, as we  have seen above, affects the activ-
ity and stability of LigIV [25,27,28,43,91–94]. XRCC4, XLF and the
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Fig. 5. Structure of human LigIV in complex with a peptide corresponding residues 485–495 of Artemis. (A) Crystal structure of the LigIV/Artemis complex (PDB code: 3W1B;
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u82])  shown together with that of the LigIV/XRCC4 complex (PDB code: 3II6; [49])
nd lime, respectively. The XRCC4 dimer (purple) is presented in a transparent-cart
rey  circles. Y298 and K345 are in sphere representation. (B) Details of the interact
RCT domains of LigIV further interact with other NHEJ proteins,
ut the functions of the complexes formed are not very clear. Here
e focus on recent structural studies of LigIV, which have provided
nsights into the catalytic and other roles of the catalytic region of
he protein.
LigIV, one of three human DNA ligases, is present in all eukary-
tes [95,96]. LigIV has the conserved catalytic region, which is
resent in the ligases, followed by tandem repeats of the BRCT
omain at the C-terminus, which are unique among the ligases.
he characteristic fold of the catalytic region can be found in
rchaeal [97–100] but not in prokaryotic DNA ligases. Since the
RCT domains of LigIV were reviewed previously [101], we focus
ere on the catalytic region of LigIV.
The catalytic region consists of the N-terminal DNA-binding
omain (DBD), a nucleotidyltransferase or adenylation domain
NTD) and an OB-fold domain (OBD) (Fig. 5A). The latter two
omains have seven conserved motifs (I, III, IIIa, IV, V, Va and VI)
102,103], most of which are essential in all nucleotidyltransferases
or  carrying out three steps of the nucleotidyltransfer reaction: the
denylation of the catalytic lysine (step 1), the transfer of AMP  to
′ phosphate (step 2) and the joining of DNA nick (step 3)[104].
he DNA ligases undergo large conformational changes during the
eaction [105]. For human and archaeal DNA ligases, there are open,
losed and DNA-bound conformations of the catalytic region in the
DB, which represent neutral, step 1 and steps 2 & 3 of the reaction,
espectively.LigIV can ligate incompatible DNA ends, across gaps at DNA ends
nd poly-T single strands [106,107]; this, with the exception of
oly-T single strands, is stimulated by Ku and XLF [106,108,109]. An
nusual characteristic of LigIV is that it is difﬁcult re-adenylate after NTD, OBD, BRCT domains and Artemis are shown in magenta, green, blue, yellow
presentation. Dotted lines denote missing loops. Inset 1 and Inset 2 lies within the
tween LigIV and Artemis. A hydrogen bond is indicated by a dotted line.
DNA ligation [110–113], a feature that is not present in the other
ligases. These observations indicate that LigIV should have unique
structural features that are absent from the other human DNA  lig-
ases, LigI and LigIII. The crystal structure of the catalytic region of
LigIV shows four unique features (Inserts 1 & 2, Y298 and K345 in
Fig. 5A) [51,82], which are probably important for the activity of
LigIV.
Insert 1 is a loop connecting 5 and 6 of DBD while Insert
2 is present within OBD. OBD in DNA ligases has the conserved
motif VI, which is essential for step 1 of DNA ligation [114]. Since
motif VI needs to come close to the catalytic pocket to hydrolyze
ATP, OBD undergoes a large conformational change to a closed con-
formation [105]. However, Inserts1 and 2 stereochemically clash
with OBD and DBD when LigIV has the closed conformation, a
possible explanation as to why  it is more difﬁcult for LigIV to
achieve the conformation and why  the readenylation of LigIV is
more difﬁcult than in other human and archaeal DNA ligases. The
difﬁculty of adenylation was  observed in LigIV without XRCC4 [92]
and LigIV/XRCC4 missing BRCT2 of LigIV [115]. Moreover, we  have
made similar observations in the dsDNA ligation assays of the cat-
alytic region of LigIV with and without ATP [82], implying that the
catalytic region of LigIV is responsible for the difﬁcultly of readeny-
lation.
XLF is known to stimulate readenylation of LigIV [25,93] and
also interacts with LigIV via the ﬁrst BRCT domain (BRCT1) [49]. It
is unclear whether interactions of XRCC4 and XLF with LigIV take
place in the context of the XRCC4/XLF ﬁlament, but they may  induce
conformational changes or stabilize the conformations of Inserts
1 and 2, in a way  that favors the closed LigIV conformation, and
stimulates adenylation.
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Dig. 6. Structural model of LigIV bound nicked dsDNA. (A) Structural model of LigIV
cheme as in Fig. 5A is used here. (B) Model of loop between 5 & 6 ﬁtting into th
A model of DNA-bound LigIV (Fig. 6A), based on the structures of
igI and LigIII in complex with nicked DNA [105,116], indicates that
nsert 1, Y298 and K345 in NTD may  be involved in the DNA-binding
ctivity of LigIV [51,82]. Insert 1 may  ﬁt into a major grove located
pposite to the DNA nick (Fig. 6B). Interestingly, the orientation of
5 with respect to 4 and 6 in DBD is different from that of the
ther human and archaeal DNA ligases. This might be correlated
ith the presence of Insert 1 and may  be important for DNA liga-
ion of the unusual substrates described above. Y298, a conserved
esidue in NTD of LigIV, could  stack with a base or sugar of DNA;
his would be possible also in organisms where LigIV has a histidine
r phenylalanine at the equivalent position.
The other residue in NTD, K345, thought to be involved in the
NA-binding activity of LigIV, is close to the 3′ OH end of the
NA nick. Most DNA ligases have phenylalanine at the equiva-
ent position, and the structures of LigI and LigIII show that the
henylalanine  stacks with the 3′ end ribose. E. coli DNA ligase
as arginine at the position, which is essential for the activity of
he ligase [117,118]. The fact that LigIV has lysine at the position
ould reﬂect the need to detect the 3′ end ﬂexibly. These unique
eatures may  allow LigIV to join different types of DNA ends so that
NA does not fall apart.
LigIII  and LigIV but not LigI have end-joining activities towards
BSs [113]. However, although most of the DNA-binding afﬁnity of
igI and LigIV come from DBD [105] (T.O. unpublished results), this
s not true of LigIII [119]. Instead, a jack-knife model of the DNA
inding of LigIII has been proposed [116,119]. Then, the question
rises as to how LigIV bridges two DNA ends. XRCC4 itself forms
rotein ﬁlaments [37,38], which might help synapsis of DNA ends.
lternatively, LigIV might bind two fragments of DNA. Note that
he linker between OBD and BRCT1 of LigIV has been shown to have
fﬁnity for DNA [120]. Moreover, the non-catalytic function of LigIV
s important for autophosphorylation of DNA-PKcs implying that
igIV is an important factor for synapsis [121]. Further biochemical
ncluding structural studies of how LigIV binds DNA are required to
esolve this issue.
In  addition to the features related to the catalytic activity, LigIV
peciﬁcally interacts with Artemis (residues 485–495) [80]. Exten-
ive hydrophobic interactions of the helical bundle mediated by
14, F42 and F49 of LigIV and W489, F492 and F493 of Artemis
ake the interaction moderately stable with 4.8 M afﬁnity [81,82]Fig. 5B). It is unclear how the interaction affects the activities of
igIV and/or Artemis. However, this interaction implies that LigIV
an be recruited at DNA ends by Artemis forming a complex with
NA-PKcs and vice versa. Thus, multiple interactions among NHEJmplex with DNA. The model was built as described previously [82]. The same color
r groove of DNA. The loop was modeled using RapperTK [171].
proteins  probably assemble them quickly and as stable complexes
at DNA ends.
Lastly, we consider the speciﬁcity of LigIV in NHEJ. As men-
tioned above LigI, III and IV are likely to join two strands in a similar
manner, suggesting that the catalytic regions of the ligases might
replace each other with retention of function. Interestingly, mito-
chondrial LigIII can be replaced with LigI, LigIV and even DNA ligases
from lower organisms [122,123]. It is difﬁcult to know whether the
catalytic regions of LigI and III replace that of LigIV because it is
unclear whether the unique features of the catalytic region of LigIV
are functionally important. However, LigI and III cannot compen-
sate for full-length LigIV in LigIV-defective mouse [124], although
LigIII can perform intermolecular ligation [113,119]. This is proba-
bly because interactions of LigIV with other macromolecules make
the protein a specialized ligase for NHEJ. The interactions may  be
important for synapsis of correct DNA ends and/or allowing LigIV
access to the ends. For instance, LigIV is speciﬁcally recruited to
DNA ends by Ku [125,126] and displaces it from DNA ends [109].
Indeed, requirement of a non-catalytic function of LigIV for NHEJ
has been reported [121]. In view of the fact that LigIV mutants
with very weak catalytic activity cause LIG4 syndrome (see below
for the details), NHEJ likely needs both catalytic and non-catalytic
functions of LigIV. However, it does not eliminate the possibility
that LigI and III ligate a tiny fraction of DSBs in the ﬁnal step of
NHEJ. Thus, it would be interesting to see whether ligases work
in NHEJ in the presence of enzymatically inactive LigIV, e.g., hav-
ing a mutation on K273, in order to see whether the mutation
causes LIG4 syndrome or embryonic lethal. When the core compo-
nents of NHEJ are missing, AEJ takes over. The zinc-ﬁnger domain
of LigIII promotes DNA ligation near single-strand gaps and ﬂaps
[127], which are likely to be intermediate states of damaged DNA
in AEJ, as well as intermolecular ligation [127,119]. The domain
interacts with PARP-1 [128], which has been reported to play a role
in AEJ [129–132]. Importantly, the zinc-ﬁnger domain is dispens-
able for microhomology-mediated AEJ [133]. Moreover, the same
authors showed that the BRCT domain of LigIII is inessential for AEJ
indicating that the ligase does not need XRCC1 for the joining. LigI
also works in an alternative pathway of DSB-end joining [133,134]
implying the existence of two different pathways for AEJ and a hier-
archy among LigIV, III and I for the end joining [133]. Although the
hierarchal mechanism remains to be elucidated, competition and
crosstalk, if present among proteins involving end joining such as
the ligases, Ku, PARP-1 and PAR, may  decide which ligase to recruit
to DSB ends. In fact, Ku directly competes with PARP-1 for DSB
repair [130].
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. NHEJ deﬁciency
Mutations in ARTEMIS, LIG4 and XLF genes are known to cause
adiosensitive immune deﬁciency. The ARTEMIS gene deﬁciency,
ost frequently reported among NHEJ genes, leads to radiosen-
itive severe-combined immunodeﬁciency (RS-SCID) or Omenn
yndrome [61,135]. Mutations vary from point mutations to null
xpression [136]. Most of the point mutants, including S32C [62],
32F [137], H35D [135], D37G [138], G118V, G135E [139] and
165V [136], are concentrated near the catalytic center of Artemis
Fig. 4A), indicating a probable loss or reduction of endonuclease
unction; this is conﬁrmed by mutagenesis studies of some of the
esidues [69,75]. Mutations of two buried residues outside the cat-
lytic center, I16T and A28P (Fig. 4A) found in some radiosensitive
mmune deﬁcient patients [136,140], are predicted by SDM anal-
sis [141] to result in structural instability of the -Lact domain.
t is difﬁcult to predict the impacts of mutations G126D [142] and
153R [137], which are located in loops (Fig. 4A), without in vitro
ata and knowing the correct conformation of loop structures from
he crystal structure of Artemis. P171 is in the loop connecting the
-Lact and -CASP domains (Fig. 4A)[143]. However, a conserved
roline, present at a similar position in the structures of SNM1A
nd Apollo, is stacked on a tyrosine in the second sub-domain of
-Lact. Since Artemis also has a tyrosine at the corresponding loca-
ion, the mutation P171R may  change local structure as proposed
y Jeggo and colleagues [143]. Three mutations causing radiosen-
itive immune deﬁciency, G211V, H228N [136] and H254L [144],
re present in the -CASP domain (Fig. 4A). At a similar position to
211, SNM1A and Apollo have G882 and G185, which are solvent
naccessible and have positive  torsion angles; therefore, G211V is
ikely to disrupt the local conformation around the residue. H254L,
ig. 8. XLF mutants in Cernunnos-XLF deﬁciency patients. (A) R57, polar interaction is in
rotein sequences are shown in grey color.Fig. 7. RS-SCID causing residues. (A) S32 and its surrounding residues. The same
color scheme used in Fig. 5A is adopted here. (B) Residues around H228 and H254.
Hydrogen bonds are indicated by dotted lines.
as indicated by a SDM analysis, destabilizes the -CASP domain
because it makes a hydrogen bond with the carbonyl oxygen of
T251 (Fig. 7). Since H228 and H254 are conserved residues in the
groove mentioned above in our discussion of end processing, they
might have important functions apart from structural roles.
LigIV/XRCC4 is important for normal growth because the knock-
out of either LIG4 or XRCC4 gene is embryonic lethal [124,145,146],
and moreover, hypomorphic mutations of LigIV or XLF in human
cause rare diseases characterized conventionally by radiosensi-
tivity, immunodeﬁciency, microcephaly, etc.; growth retardation
and microcephaly caused by mutations in LIG4 are classiﬁed as LIG4
syndrome [147,148]. Recent crystallographic studies of human
dicated by grey dashed line; (B) C123; (C) A25-R57 deletion. (D) R178X. Deletion
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igIV have shed light on some point mutations, such as A3V, T9I,
249V, R278H, Q280R, H282L and G469E, which are found in LIG4
yndrome patients [149–155]. A3 and T9 are located in the ﬂex-
ble N-terminal region and the beginning of the ﬁrst -helix of
BD, respectively. The residues before T6 were not observed in the
rystal structures of DBD [81,82], indicating that A3V is unlikely to
ffect structural stability or activity of LigIV. However, the increase
f hydrophobicity [150] in an exposed, unstructured region caused
y substitution of alanine by valine could introduce non-speciﬁc
rotein-protein interactions, which may  interfere with the activity
f LigIV. T9 stabilizes the conformation of a short -helix connected
o the following helix by a kink produced by a VPF motif. Mutation
9I may  alter the local conformation, affecting the interaction with
rtemis and/or DNA. The mutation increases the risk of develop-
ng severe radiation pneumonitis in some patients after radiation
herapy [156]. Interestingly, A3V and T9I have protective effects
n the development of multiple myeloma but cause severe clinical
henotypes when combined with R278H [157].
M249, R278, Q280, H282 and Y288, all located in NTD, are likely
o be important for structural stability of the ATP-binding pocket.
278 is the only residue of this group that might interact directly
ith ATP [111]. R278, Q280 and H282 stabilize the conformation
f the region that inﬂuences interactions between the two  sub-
omains of NTD. Since the ATP-binding pocket lies between the
ubdomains, it is likely that M249V, R278H, Q280R and H282L
ead to instability or conformational change in the ATP-binding
ocket, resulting in a large reduction of the adenylation efﬁciency
s reported for R278H [149]. G469, a residue in motif Va, which is
mportant for the adenylation of LigIV [103], is completely buried
nd surrounded by large hydrophobic residues. Therefore, it is
ikely that G469E leads to disruption of the conformation of OBD.
In summary, apart from A3V and T9I, point mutations found
n LIG4 syndrome mutations cause conformational changes and/or
tructural instabilities in LigIV.
Five patients, who have Cernunnos-XLF deﬁciency caused by
utations in XLF gene, have been identiﬁed so far [33]. These
utations, involving deletion between A25-R57, R57G, C123R, and
178X and resulting in truncated putative proteins, lead to severely
educed protein levels. Mutation of R57G (2) results in loss of R57
ide chain interactions with E47 (4) and N120 (7), which are
rucial for maintaining the -sandwich structure (Fig. 8A). C123R
7) mutation disrupts its hydrophobic core environment created
y W45  (4), E47 (4), Y34 (3), L36 (3), V38 (3), L104 (6), L106
6) and F121 (7) (Fig. 8B). Deletion of residues between A25-R57
eads to the absence of 2-4 and half of 2 (Fig. 8C). Therefore A25-
57 deletion, R57G and C123R mutations can destabilize the XLF
ead domain structure and affect its function. Biochemical experi-
ents on XLF mutant R57G also show that change of head domain
onformation can result in loss of XLF ability to translocate into the
ucleus properly [27]. R178X mutant is missing the fold back struc-
ure (5, 6) and ﬂexible C-terminal of XLF (Fig. 8D). Therefore it
acks the helix to maintain its homodimer structure, and region for
NA interaction and Ku binding.
. Conclusion
Recent studies of NHEJ proteins have revealed diverse func-
ions, which emphasize the need to reconsider the conventional
HEJ model. In this review we have focused on structural aspects
f interactions of LigIV with XRCC4, XLF, Artemis and DNA, seek-
ng to use these to inform our understanding of the spatial and
emporal organization of NHEJ. We  show that structural studies
f LigIV/XRCC4/XLF and LigIV/Artemis complexes can shed light
n their interactions at an amino-acid level, which can then be
nvestigated in vivo using site-directed mutagenesis. 17 (2014) 98–109
The  DNA-double-strand-break repair process is an example of
the complexity of multicomponent systems in the cell that are
required to assemble and disassemble in response to signals from
outside. The complexity ensures the proper colocation of compo-
nents in space and time, and thus accurate and timely responses to
signals outwith and within NHEJ both in immune cells and when
DNA damage occurs.
Knowledge  of the spatial organization and interactions between
the many components of NHEJ will likely be useful for developing
speciﬁc inhibitors to block the NHEJ pathway. Indeed, inhibitors
of human DNA ligases including LigIV have been studied [158]
and recently demonstrated to be potential drugs for cancer ther-
apy [159]. With developing expertise in targeting protein–protein
interactions [160], these complex molecular assemblies of known
structure will likely become attractive targets for the development
of therapeutic agents that can be used in combination with classical
radio or chemotherapy.
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